logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
12/09/2025
Sino-US declaration: Unordered fluctuations in exchange rates may have adverse effects on economic and financial stability.
Latest
2 m ago
Hong Kong stocks surged | Meitu Company (01357.HK) rose more than 5%, joining hands with Tongyi Wanxiang to continue promoting the industrialization of AIGC technology in multiple fields.
3 m ago
In the first half of the year, market regulation departments have achieved significant results in cracking down on infringement and counterfeiting.
4 m ago
Gao Jianhui, former director-level inspector of the Henan Provincial Committee inspection team, is under disciplinary review and investigation by the supervisory authorities.
5 m ago
The three major indices collectively turned red.
6 m ago
Hong Kong stocks news | Pharmaron Health-B (02617.HK) rises by over 18% again, with a total market value exceeding HK$50 billion. The phase II trial of Tenofovir Alafenamide for breast cancer was approved.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.